PEGFILGRASTIM-CBQV

PEGFILGRASTIM-CBQV was reported 1434 times

PEGFILGRASTIM-CBQV is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERISPLENITIS 1 0.5000
1 ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 1 0.0526
2 SCAN 1 0.0476
3 NON-SMALL CELL LUNG CANCER STAGE III 1 0.0294
4 LUNG SQUAMOUS CELL CARCINOMA STAGE IV 1 0.0149
5 WRONG PRODUCT STORED 4 0.0141
6 DEVICE MALFUNCTION 915 0.0130
7 APPLICATION SITE INDURATION 2 0.0118
8 RHABDOMYOSARCOMA 2 0.0106
9 DEVICE INTOLERANCE 2 0.0084
10 ENDOMETRIAL CANCER RECURRENT 1 0.0076
11 SPLINTER HAEMORRHAGES 1 0.0073
12 GLOMERULAR VASCULAR DISORDER 1 0.0067
13 PRODUCT PACKAGING CONFUSION 16 0.0066
14 PRODUCT LABEL CONFUSION 36 0.0062
15 PAIN MANAGEMENT 1 0.0059
16 EXPULSION OF MEDICATION 3 0.0057
17 ARM AMPUTATION 1 0.0055
18 RADIATION ASSOCIATED PAIN 1 0.0048
19 PRODUCT APPEARANCE CONFUSION 4 0.0043
20 NO ADVERSE EVENT 715 0.0039
21 BLOOD BILIRUBIN DECREASED 2 0.0032
22 METASTASES TO OVARY 1 0.0031
23 DUPLICATE THERAPY ERROR 1 0.0031
24 COLORECTAL ADENOMA 1 0.0031
25 DIVERTICULITIS INTESTINAL PERFORATED 1 0.0028
26 SCAN ABNORMAL 1 0.0027
27 BONE MARROW INFILTRATION 1 0.0026
28 DRUG DELIVERY SYSTEM ISSUE 5 0.0025
29 PRODUCT CONFUSION 2 0.0025
30 DEVICE FAILURE 38 0.0025
31 PSEUDOMONAL BACTERAEMIA 2 0.0023
32 FIBROADENOMA OF BREAST 1 0.0022
33 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
34 MEDICAL DEVICE SITE PAIN 1 0.0018
35 DEVICE INFUSION ISSUE 4 0.0016
36 AORTITIS 1 0.0015
37 NEUROENDOCRINE CARCINOMA 1 0.0014
38 SMALL CELL LUNG CANCER 2 0.0013
39 MALIGNANT ASCITES 1 0.0013
40 PSEUDOMONAS TEST POSITIVE 1 0.0012
41 CONGENITAL CARDIOVASCULAR ANOMALY 1 0.0012
42 TREATMENT DELAYED 2 0.0012
43 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
44 MUSCLE NECROSIS 1 0.0011
45 BLOOD URINE 1 0.0010
46 APPLICATION SITE BRUISE 1 0.0010
47 HYPOCHROMIC ANAEMIA 1 0.0010
48 BREAST NEOPLASM 1 0.0010
49 BLAST CELL COUNT INCREASED 1 0.0010
50 INTERCEPTED MEDICATION ERROR 4 0.0009
51 TONGUE HAEMORRHAGE 1 0.0009
52 FULL BLOOD COUNT INCREASED 1 0.0008
53 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
54 GLUCOSE URINE PRESENT 1 0.0008
55 OBSTRUCTION GASTRIC 1 0.0008
56 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
57 SYRINGE ISSUE 13 0.0007
58 NEUTROPHIL COUNT DECREASED 30 0.0007
59 DRUG SPECIFIC ANTIBODY 1 0.0007
60 PANCREATIC CARCINOMA METASTATIC 2 0.0007
61 MALIGNANT PLEURAL EFFUSION 1 0.0006
62 WRONG PRODUCT ADMINISTERED 4 0.0006
63 SPLENIC INFARCTION 1 0.0006
64 MASTECTOMY 1 0.0006
65 DEVICE LEAKAGE 24 0.0006
66 PRODUCT DOSE OMISSION ISSUE 159 0.0005
67 PRODUCT LEAKAGE 3 0.0005
68 CHEMOTHERAPY 2 0.0005
69 NEEDLE ISSUE 15 0.0005
70 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
71 APPLICATION SITE DISCOLOURATION 2 0.0005
72 NEUTROPENIC COLITIS 1 0.0005
73 EYE CONTUSION 1 0.0005
74 METASTATIC NEOPLASM 2 0.0005
75 DEVICE ADHESION ISSUE 7 0.0005
76 ENDOMETRIAL CANCER 1 0.0005
77 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
78 BLOOD LOSS ANAEMIA 1 0.0004
79 NEUTROPENIC SEPSIS 3 0.0004
80 URINE FLOW DECREASED 1 0.0004
81 OXYGEN CONSUMPTION INCREASED 1 0.0004
82 APPLICATION SITE SWELLING 2 0.0004
83 APPENDICITIS PERFORATED 1 0.0004
84 INJURY ASSOCIATED WITH DEVICE 8 0.0004
85 COMPARTMENT SYNDROME 1 0.0004
86 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
87 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
88 APPLICATION SITE HAEMORRHAGE 1 0.0004
89 BONE PAIN 21 0.0004
90 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
91 INJECTION SITE HYPERSENSITIVITY 1 0.0003
92 NON-CARDIAC CHEST PAIN 1 0.0003
93 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
94 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
95 NEOPLASM RECURRENCE 1 0.0003
96 FULL BLOOD COUNT ABNORMAL 3 0.0003
97 APPENDICECTOMY 1 0.0003
98 DEVICE USE ERROR 9 0.0003
99 RHINOVIRUS INFECTION 1 0.0003
100 OBSTRUCTION 1 0.0003
101 ORGAN FAILURE 1 0.0002
102 HYPERURICAEMIA 1 0.0002
103 GASTROINTESTINAL PERFORATION 1 0.0002
104 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
105 DEVICE USE ISSUE 4 0.0002
106 APPLICATION SITE PAIN 5 0.0002
107 FEBRILE NEUTROPENIA 15 0.0002
108 VASCULAR DEVICE INFECTION 1 0.0002
109 DISEASE COMPLICATION 1 0.0002
110 GASTRITIS EROSIVE 1 0.0002
111 SKIN ABRASION 1 0.0002
112 PROTEIN URINE PRESENT 1 0.0002
113 INSURANCE ISSUE 3 0.0002
114 CACHEXIA 1 0.0002
115 TRISMUS 1 0.0002
116 EXPOSURE VIA SKIN CONTACT 5 0.0002
117 SKIN NECROSIS 1 0.0002
118 BLOOD LACTIC ACID INCREASED 1 0.0002
119 DEVICE ISSUE 17 0.0002
120 HIP SURGERY 1 0.0002
121 PRODUCT DISPENSING ERROR 4 0.0002
122 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
123 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
124 GASTROINTESTINAL PAIN 2 0.0002
125 STREPTOCOCCAL INFECTION 1 0.0002
126 INTENTIONAL DOSE OMISSION 5 0.0002
127 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
128 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
129 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
130 PLATELET COUNT ABNORMAL 1 0.0002
131 TREATMENT NONCOMPLIANCE 9 0.0002
132 DEVICE DISLOCATION 7 0.0002
133 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
134 INCOHERENT 1 0.0002
135 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
136 METASTASES TO LYMPH NODES 1 0.0001
137 PRODUCT PREPARATION ERROR 3 0.0001
138 PAIN IN JAW 4 0.0001
139 DIVERTICULUM 1 0.0001
140 INTENTIONAL UNDERDOSE 1 0.0001
141 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
142 TROPONIN INCREASED 1 0.0001
143 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
144 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
145 APHTHOUS ULCER 1 0.0001
146 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
147 ULCER 2 0.0001
148 GINGIVAL PAIN 1 0.0001
149 PRODUCT QUALITY ISSUE 17 0.0001
150 CANDIDA INFECTION 2 0.0001
151 NEUTROPENIA 16 0.0001
152 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
153 BLOOD MAGNESIUM DECREASED 1 0.0001
154 DEATH 99 0.0001
155 APPLICATION SITE ERYTHEMA 3 0.0001
156 PRODUCT COMMUNICATION ISSUE 1 0.0001
157 LEUKOCYTOSIS 2 0.0001
158 PNEUMONITIS 3 0.0001
159 OVARIAN CANCER 1 0.0001
160 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
161 NEOPLASM MALIGNANT 7 0.0001
162 HOSPITALISATION 16 0.0001
163 PANCREATIC CARCINOMA 3 0.0001
164 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
165 THERAPY CHANGE 1 0.0001
166 HOSPICE CARE 1 0.0001
167 LIGAMENT SPRAIN 1 0.0001
168 BLOOD PRESSURE ABNORMAL 2 0.0001
169 BLOOD POTASSIUM DECREASED 3 0.0001
170 FULL BLOOD COUNT DECREASED 2 0.0001
171 TENDERNESS 1 0.0001
172 WEIGHT FLUCTUATION 1 0.0001
173 BREAST PAIN 1 0.0001
174 BREAST CANCER METASTATIC 1 0.0001
175 SEPTIC SHOCK 4 0.0001
176 OESOPHAGITIS 1 0.0001
177 INTERNAL HAEMORRHAGE 1 0.0001
178 ELECTROLYTE IMBALANCE 1 0.0001
179 SPLENOMEGALY 1 0.0001
180 SPINAL PAIN 1 0.0001
181 THERAPY INTERRUPTED 6 0.0001
182 SMALL INTESTINAL OBSTRUCTION 1 0.0001
183 ILEUS 1 0.0001
184 CELLULITIS 4 0.0001
185 RESPIRATORY TRACT INFECTION 2 0.0001
186 IMMUNE SYSTEM DISORDER 1 0.0001
187 TOOTH INFECTION 1 0.0001
188 SARS-COV-2 TEST POSITIVE 1 0.0001
189 PLATELET COUNT DECREASED 8 0.0001
190 JAUNDICE 2 0.0001
191 BLOOD TEST ABNORMAL 1 0.0001
192 SEASONAL ALLERGY 1 0.0001
193 RED BLOOD CELL COUNT DECREASED 2 0.0001
194 PRODUCT STORAGE ERROR 6 0.0001
195 PULMONARY MASS 1 0.0001
196 COLON CANCER 1 0.0001
197 HYPOAESTHESIA ORAL 1 0.0001
198 STOMATITIS 4 0.0001
199 THYROID DISORDER 1 0.0001
200 ABSCESS 1 0.0001
201 METASTASES TO BONE 1 0.0001
202 MUSCULOSKELETAL DISCOMFORT 1 0.0001
203 NEOPLASM PROGRESSION 2 0.0001
204 BURNING SENSATION 4 0.0001
205 INCORRECT DOSE ADMINISTERED 13 0.0001
206 METASTASES TO LIVER 1 0.0001
207 GASTROENTERITIS VIRAL 1 0.0001
208 AGRANULOCYTOSIS 1 0.0001
209 SEPSIS 6 0.0001
210 HEPATIC STEATOSIS 1 0.0001
211 BACTERIAL INFECTION 1 0.0001
212 DYSARTHRIA 2 0.0001
213 BLOOD SODIUM DECREASED 1 0.0001
214 COLITIS 2 0.0001
215 FOOT FRACTURE 1 0.0001
216 GASTRIC ULCER 1 0.0001
217 DEHYDRATION 7 0.0001
218 DYSPHONIA 3 0.0001
219 CHOKING 1 0.0001
220 SKIN FISSURES 1 0.0001
221 HEART RATE INCREASED 5 0.0001
222 HAEMATOCRIT DECREASED 1 0.0001
223 UPPER LIMB FRACTURE 1 0.0001
224 PRESCRIBED UNDERDOSE 1 0.0001
225 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
226 CYTOKINE RELEASE SYNDROME 1 0.0000
227 THROMBOSIS 4 0.0000
228 PRODUCT ADMINISTRATION ERROR 1 0.0000
229 TASTE DISORDER 1 0.0000
230 FLUSHING 5 0.0000
231 BODY TEMPERATURE INCREASED 1 0.0000
232 LUNG NEOPLASM MALIGNANT 2 0.0000
233 WITHDRAWAL SYNDROME 2 0.0000
234 BACK PAIN 11 0.0000
235 FAECES DISCOLOURED 1 0.0000
236 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
237 ORAL PAIN 1 0.0000
238 SNEEZING 1 0.0000
239 PERICARDIAL EFFUSION 1 0.0000
240 CHEST PAIN 8 0.0000
241 ARRHYTHMIA 2 0.0000
242 PRODUCT PRESCRIBING ERROR 1 0.0000
243 DIABETIC KETOACIDOSIS 1 0.0000
244 MENTAL IMPAIRMENT 1 0.0000
245 RESPIRATORY FAILURE 3 0.0000
246 PRESYNCOPE 1 0.0000
247 UNEVALUABLE EVENT 3 0.0000
248 PRODUCT COMPLAINT 1 0.0000
249 LOSS OF CONSCIOUSNESS 5 0.0000
250 RASH GENERALISED 1 0.0000
251 MUSCLE SPASMS 7 0.0000
252 JOINT STIFFNESS 1 0.0000
253 EAR INFECTION 1 0.0000
254 PYREXIA 13 0.0000
255 THROAT TIGHTNESS 1 0.0000
256 PALLOR 1 0.0000
257 ANAPHYLACTIC REACTION 2 0.0000
258 MENTAL STATUS CHANGES 1 0.0000
259 HAEMOPTYSIS 1 0.0000
260 NECK PAIN 2 0.0000
261 EYE PAIN 2 0.0000
262 HYPERSOMNIA 1 0.0000
263 LETHARGY 2 0.0000
264 INFECTION 5 0.0000
265 DYSSTASIA 1 0.0000
266 SURGERY 2 0.0000
267 NASAL CONGESTION 2 0.0000
268 ACUTE MYOCARDIAL INFARCTION 1 0.0000
269 LABORATORY TEST ABNORMAL 1 0.0000
270 PLEURAL EFFUSION 2 0.0000
271 SWOLLEN TONGUE 1 0.0000
272 CYSTITIS 1 0.0000
273 HYPOTHYROIDISM 1 0.0000
274 HYPERHIDROSIS 4 0.0000
275 DEEP VEIN THROMBOSIS 2 0.0000
276 SWELLING FACE 2 0.0000
277 CHOLELITHIASIS 1 0.0000
278 IMPAIRED HEALING 1 0.0000
279 BLOOD PRESSURE DECREASED 2 0.0000
280 LIP SWELLING 1 0.0000
281 FUNGAL INFECTION 1 0.0000
282 VOMITING 14 0.0000
283 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
284 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
285 HAEMOGLOBIN DECREASED 3 0.0000
286 ILLNESS 3 0.0000
287 NIGHTMARE 1 0.0000
288 PRODUCT ADHESION ISSUE 1 0.0000
289 MOBILITY DECREASED 2 0.0000
290 MYELOSUPPRESSION 1 0.0000
291 ACCIDENTAL OVERDOSE 1 0.0000
292 DYSURIA 1 0.0000
293 INJECTION SITE MASS 1 0.0000
294 EPISTAXIS 2 0.0000
295 DYSPNOEA 15 0.0000
296 PLASMA CELL MYELOMA 1 0.0000
297 ALOPECIA 5 0.0000
298 NAUSEA 20 0.0000
299 BLINDNESS 1 0.0000
300 PAIN 15 0.0000
301 TREATMENT FAILURE 2 0.0000
302 TREMOR 4 0.0000
303 POLLAKIURIA 1 0.0000
304 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
305 CARDIO-RESPIRATORY ARREST 1 0.0000
306 URTICARIA 4 0.0000
307 CONSTIPATION 5 0.0000
308 MALAISE 10 0.0000
309 COVID-19 4 0.0000
310 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
311 NEPHROLITHIASIS 1 0.0000
312 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
313 HYPERSENSITIVITY 4 0.0000
314 DECREASED APPETITE 5 0.0000
315 ABDOMINAL PAIN 5 0.0000
316 SWELLING 2 0.0000
317 PRODUCT USE ISSUE 4 0.0000
318 ASTHENIA 8 0.0000
319 PRODUCTIVE COUGH 1 0.0000
320 FEELING ABNORMAL 5 0.0000
321 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
322 HEADACHE 13 0.0000
323 SYNCOPE 2 0.0000
324 HYPOTENSION 4 0.0000
325 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
326 SINUSITIS 2 0.0000
327 THERAPY CESSATION 1 0.0000
328 BRADYCARDIA 1 0.0000
329 DIARRHOEA 12 0.0000
330 OEDEMA 1 0.0000
331 RASH 8 0.0000
332 INFLUENZA 2 0.0000
333 PANCYTOPENIA 1 0.0000
334 ABDOMINAL DISCOMFORT 3 0.0000
335 THROMBOCYTOPENIA 2 0.0000
336 OXYGEN SATURATION DECREASED 1 0.0000
337 MYALGIA 3 0.0000
338 MUSCULAR WEAKNESS 2 0.0000
339 HERPES ZOSTER 1 0.0000
340 SEIZURE 2 0.0000
341 OFF LABEL USE 15 0.0000
342 FEELING HOT 1 0.0000
343 EXPOSURE DURING PREGNANCY 1 0.0000
344 ANAEMIA 3 0.0000
345 PNEUMONIA 5 0.0000
346 FATIGUE 12 0.0000
347 AMNESIA 1 0.0000
348 BLOOD CREATININE INCREASED 1 0.0000
349 DEVICE DIFFICULT TO USE 1 0.0000
350 INFUSION RELATED REACTION 1 0.0000
351 FALL 5 0.0000
352 ANXIETY 4 0.0000
353 BRONCHITIS 1 0.0000
354 HYPOAESTHESIA 2 0.0000
355 DEPRESSION 3 0.0000
356 CHRONIC KIDNEY DISEASE 1 0.0000
357 DIABETES MELLITUS 1 0.0000
358 BLOOD PRESSURE INCREASED 2 0.0000
359 INJECTION SITE PAIN 4 0.0000
360 PRURITUS 5 0.0000
361 PARAESTHESIA 2 0.0000
362 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
363 CONFUSIONAL STATE 2 0.0000
364 INFLUENZA LIKE ILLNESS 1 0.0000
365 CARDIAC ARREST 1 0.0000
366 ARTHRALGIA 5 0.0000
367 URINARY TRACT INFECTION 2 0.0000
368 MUSCULOSKELETAL STIFFNESS 1 0.0000
369 DRUG INEFFECTIVE 15 0.0000
370 INSOMNIA 3 0.0000
371 TACHYCARDIA 1 0.0000
372 GASTROINTESTINAL DISORDER 1 0.0000
373 ADVERSE DRUG REACTION 1 0.0000
374 ADVERSE EVENT 1 0.0000
375 OROPHARYNGEAL PAIN 1 0.0000
376 WEIGHT DECREASED 3 0.0000
377 COUGH 3 0.0000
378 DYSPHAGIA 1 0.0000
379 NEUROPATHY PERIPHERAL 1 0.0000
380 MIGRAINE 1 0.0000
381 PAIN IN EXTREMITY 3 0.0000
382 CHEST DISCOMFORT 1 0.0000
383 ERYTHEMA 2 0.0000
384 ABDOMINAL DISTENSION 1 0.0000
385 HAEMORRHAGE 1 0.0000
386 OVERDOSE 2 0.0000
387 ASTHMA 1 0.0000
388 PALPITATIONS 1 0.0000
389 DISEASE PROGRESSION 1 0.0000
390 VISUAL IMPAIRMENT 1 0.0000
391 INJECTION SITE ERYTHEMA 1 0.0000
392 RENAL FAILURE 1 0.0000
393 DRY SKIN 1 0.0000
394 MEMORY IMPAIRMENT 1 0.0000
395 ACUTE KIDNEY INJURY 1 0.0000
396 DRUG INTERACTION 1 0.0000
397 DIZZINESS 3 0.0000
398 CEREBROVASCULAR ACCIDENT 1 0.0000
399 MYOCARDIAL INFARCTION 1 0.0000
400 NASOPHARYNGITIS 1 0.0000
401 GAIT DISTURBANCE 1 0.0000
402 SOMNOLENCE 1 0.0000
403 ABDOMINAL PAIN UPPER 1 0.0000